Competitive oxidation of key pentose phosphate pathway enzymes modulates the fate of intermediates and NAPDH production

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

The oxidative phase of the pentose phosphate pathway (PPP) involving the enzymes glucose-6-phosphate dehydrogenase (G6PDH), 6-phosphogluconolactonase (6PGL), and 6-phosphogluconate dehydrogenase (6PGDH), is critical to NADPH generation within cells, with these enzymes catalyzing the conversion of glucose-6-phosphate (G6P) into ribulose-5-phosphate (Ribu5-P). We have previously studied peroxyl radical (ROO) mediated oxidative inactivation of E. coli G6PDH, 6PGL, and 6PGDH. However, these data were obtained from experiments where each enzyme was independently exposed to ROO, a condition not reflecting biological reality. In this work we investigated how NADPH production is modulated when these enzymes are jointly exposed to ROO. Enzyme mixtures (1:1:1 ratio) were exposed to ROO produced from thermolysis of 100 mM 2,2′-azobis(2-methylpropionamidine) dihydrochloride (AAPH). NADPH was quantified at 340 nm, and protein oxidation analyzed by liquid chromatography with mass spectrometric detection (LC-MS). The data obtained were rationalized using a mathematical model. The mixture of non-oxidized enzymes, G6P and NADP+ generated ∼175 μM NADPH. Computational simulations showed a constant decrease of G6P associated with NADPH formation, consistent with experimental data. When the enzyme mixture was exposed to AAPH (3 h, 37 °C), lower levels of NADPH were detected (∼100 μM) which also fitted with computational simulations. LC-MS analyses indicated modifications at Tyr, Trp, and Met residues but at lower concentrations than detected for the isolated enzymes. Quantification of NADPH generation showed that the pathway activity was not altered during the initial stages of the oxidations, consistent with a buffering role of G6PDH towards inactivation of the oxidative phase of the pathway.

OriginalsprogEngelsk
TidsskriftFree Radical Biology and Medicine
Vol/bind222
Sider (fra-til)505-518
ISSN0891-5849
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
This work was supported by Fondecyt grants n\u00B0 1220459 (to CLA) and 3220507 (to JSR), and the Novo Nordisk Foundation (Laureate grant: NNF20SA0064214 to MJD). CLA thanks FONDEQUIP (EQM230048) for an equipment grant.

Publisher Copyright:
© 2024 Elsevier Inc.

ID: 399110325